Advanced Bloodwork
Comprehensive Biomarker Panel
Physician-selected bloodwork to investigate current concerns and clarify risk, with markers chosen for your symptoms, history, and goals.
About Advanced Bloodwork
Bloodwork may assess cardiovascular, metabolic, inflammatory, hormonal, hepatic, renal, or nutritional health. The markers selected depend on your symptoms, history, existing information, and the questions we need to answer.
We don't run every test that exists. We run the tests that change clinical decisions. Each marker on the panel earns its place because it answers a specific question, predicts a specific outcome, or guides a specific intervention.
Most patients have a single morning blood draw, fasted, with results back within several days for review.
The clinical significance
Relevant lab markers can help clarify contributors to current symptoms or refine an assessment of future risk. Your physician considers which tests could change your care.
Markers such as apoB, Lp(a), glucose, and thyroid measures can provide useful information when selected for an appropriate clinical question. Results are considered alongside medical history, other findings, and individual risk.
We explain the meaning and limitations of results in clinical context, including reference ranges, relevant evidence, symptoms, and your priorities.
Specific markers and outputs
- Cardiovascular: apoB, Lp(a), full lipid panel, hsCRP, homocysteine
- Metabolic: fasting glucose, fasting insulin, HOMA-IR, HbA1c, uric acid
- Hepatic and renal: full liver panel including GGT, kidney function, electrolytes
- Hormonal screening: thyroid (TSH, free T4, free T3), DHEA-S, cortisol when indicated
- Nutritional: vitamin D, B12, folate, ferritin, magnesium, omega-3 index
- Hematologic: complete blood count with differential
Who we typically order this for
- Anyone whose annual labs come back 'normal' but who suspects something more useful could be measured.
- Patients with a family history of cardiovascular disease, diabetes, autoimmune disease, or cancer.
- Anyone who wants a real baseline against which to measure changes from training, nutrition, or therapy.
- Patients on medications who want a careful look at how those medications are affecting metabolism, lipids, or inflammation.
The practical experience
- A single morning blood draw, fasted (water and medications as usual unless directed otherwise).
- We sit down to walk through every meaningful result in plain language, in the context of the rest of your evaluation.
- Your physician discusses priorities and practical next steps. Written summaries and follow-up testing are agreed individually based on your needs.
Reading the numbers in context
Each marker is interpreted alongside your symptoms, history, goals, and other relevant available results. Not everyone needs imaging, fitness testing, or a full panel.
Reference ranges are starting points, not goals. We're focused on optimal ranges supported by outcome data — which often differ meaningfully from the broader reference intervals printed on the report.
The most important markers are usually re-checked every 6 to 12 months while we make changes, then less frequently once stable. Less critical markers may only need annual or every-other-year tracking.
Frequently asked
What's the difference between this and the labs my primary care doctor ordered?
We review the labs you already have and discuss whether other markers could answer relevant questions about your current concerns or risk. Markers such as apoB or Lp(a) may be useful in some situations. Your physician explains the selection and integrates the results into your plan; there is no required standard panel.
Do I need to fast?
Yes — at least 10 hours, water and most medications as usual. Specific instructions are provided ahead of your draw.
How often should I re-test?
It depends on the marker. Lipids and metabolic markers are usually rechecked every 6 to 12 months while we're actively making changes. Once results are stable, annual tracking is typically sufficient.
What the evidence shows
- Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295.
- Epstein E, et al. Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank. Eur J Prev Cardiol. 2025.41,099 patients with 10+ years of follow-up — cardiovascular risk was already elevated at just 2% ApoB/LDL-particle discordance.
Advanced Bloodwork can be part of your custom workup.
Your physician recommends testing when it can help answer questions about your symptoms, history, goals, and risk. Not everyone needs this test. We agree on the workup, deliverables, and fees before proceeding, and interpret results alongside your existing health information to guide your plan.